Atlas Trials

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

Clinical trial NCT01117948 · TERMINATED

Trial details

NCT number
NCT01117948
Sponsor
JSW Lifesciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer´s Disease
Start date
2009-09-01
Primary completion
2011-04-01
Enrollment
219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.